Illumina, Inc. (ILMN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:42AM EDT. Market open.
| Previous close | 124.68 |
| Open | 125.95 |
| Bid | 123.58 x 100 |
| Ask | 124.33 x 200 |
| Day's range | 122.22 - 126.21 |
| 52-week range | 89.00 - 213.91 |
| Volume | |
| Avg. volume | 1,621,593 |
| Market cap | 19.773B |
| Beta (5Y monthly) | 1.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Analysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out for
AbCellera Biologics (ABCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Gear Up for Illumina (ILMN) Q1 Earnings: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Illumina (ILMN) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- Zacks
Illumina (ILMN) Expected to Beat Earnings Estimates: Should You Buy?
Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.